CQC regulated clinic | Enjoy £10 off with code Welcome10
Notice: Due to high demand, we are experiencing delays in processing orders. Orders may take up to 5-7 extra working days to process. Prices remain the same until 1st September before the Mounjaro price increase. Thank you for your patience. For the latest updates, follow us on Instagram.
1️⃣ Mounjaro and Wegovy are both injectable medications aimed at weight loss but have distinct mechanisms of action.
2️⃣ Mounjaro targets both GLP-1 and GIP receptors, offering broader metabolic benefits. Wegovy acts solely on the GLP-1 receptor, aiding weight loss by suppressing appetite.
3️⃣ Mounjaro shows higher efficacy in weight loss compared to Wegovy but may carry unique safety considerations.
4️⃣ Both options have similar gastrointestinal side effects, but their dosage and administration vary.
5️⃣ Consulting with a healthcare provider is essential to determine the most suitable option.
When exploring weight loss injections, two names frequently emerge: Mounjaro and Wegovy. These medications have gained popularity due to their effectiveness in helping individuals with obesity or related health conditions achieve significant weight loss.
Both Mounjaro (tirzepatide) and Wegovy (semaglutide) belong to a class of medications known as GLP-1 receptor agonists. However, Mounjaro goes a step further by also targeting GIP receptors, which may contribute to its superior weight loss outcomes.
While both drugs work by suppressing appetite, slowing gastric emptying, and improving insulin sensitivity, Mounjaro’s dual-action approach means it may offer additional benefits for fat metabolism and blood sugar regulation. This makes it an appealing option, especially for individuals also managing type 2 diabetes.
For more information on our weight loss treatments, visit our Treatments page.
Clinical trials demonstrate that Wegovy helps users lose approximately 15% of their body weight over 68 weeks with the maximum dosage of 2.4 mg per week. Meanwhile, Mounjaro has shown even greater efficacy, with weight loss ranging from 15% to 22.5%, depending on the dose.
In comparative studies, about 84% of patients taking Wegovy achieved at least a 5% weight loss, whereas Mounjaro’s highest dose saw 96% of participants hitting the same mark. This stark difference highlights Mounjaro’s potential for more substantial weight reduction, making it a strong contender for those aiming for significant change.
Both medications share common gastrointestinal side effects, including:
*Nausea
*Vomiting
*Diarrhea
*Constipation
*Abdominal pain
However, there are some distinctions. Wegovy may also cause fatigue, headache, and dizziness, while Mounjaro has been linked to thyroid C-cell tumors in animal studies, though the relevance to humans remains uncertain.
To learn more about the available weight loss injections, check out our Medications and Pricing page.
When considering Mounjaro vs. Wegovy, several factors can influence your choice:
For a comprehensive guide on getting started with your weight loss journey, visit our Get Started page.
Choosing between Mounjaro and Wegovy involves weighing the potential benefits against side effects and personal health factors. While Mounjaro may offer superior weight loss outcomes, Wegovy remains a reliable option, particularly for those prioritizing GLP-1-specific effects. Consulting a healthcare professional can ensure that you choose the right path for your weight loss goals.
Information
Need Help?
Instant answers
We’ll aim to reply within 2 hours
Open Mon- Fri 10am- 2pm
© 2025 Lotus Health Co. Ltd | Company Number: 13982460
Our CQC Number: 1-21252840589 | Our Partner Pharmacy is SignatureRx | GPhC Number: 9012267
Login to reorder..
